The disclosure relates to a method of producing induced beta cells from urine-derived cells, the method comprising providing urine-derived cells; inducing the urine-derived cells by culturing said urine-derived cells in a primary induction culture medium comprising an effective amount of at least one small molecule reprogramming factor(s) for a first period of time to obtain induced endoderm cells; inducing the induced endoderm cells by culturing said induced endoderm cells in a secondary induction culture medium comprising an effective amount of at least one small molecule reprogramming factor(s) for a second period of time to obtain induced pancreatic precursor cells; and inducing the induced pancreatic precursor cells by culturing said pancreatic precursor cells in a tertiary induction culture medium comprising an effective amount of at least one small molecule reprogramming factor(s) for a third period of time to obtain induced beta cells.
本公开涉及一种从尿液衍生细胞生产诱导β细胞的方法,该方法包括提供尿液衍生细胞;通过在包含有效量的至少一种小分子重编程因子的初级诱导
培养基中培养所述尿液衍生细胞一段时间来诱导尿液衍生细胞,以获得诱导内胚层细胞;在含有有效量的至少一种小分子重编程因子的二级诱导
培养基中培养诱导的内胚层细胞一段时间,以获得诱导的胰腺前体细胞;以及在含有有效量的至少一种小分子重编程因子的三级诱导
培养基中培养诱导的胰腺前体细胞一段时间,以获得诱导的β细胞。